These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 2564629)

  • 1. Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.
    Bristow MR; Hershberger RE; Port JD; Minobe W; Rasmussen R
    Mol Pharmacol; 1989 Mar; 35(3):295-303. PubMed ID: 2564629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.
    Bristow MR; Ginsburg R; Umans V; Fowler M; Minobe W; Rasmussen R; Zera P; Menlove R; Shah P; Jamieson S
    Circ Res; 1986 Sep; 59(3):297-309. PubMed ID: 2876788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta 1-adrenergic selectivity of the new cardiotonic agent denopamine in its stimulating effects on adenylate cyclase.
    Inamasu M; Totsuka T; Ikeo T; Nagao T; Takeyama S
    Biochem Pharmacol; 1987 Jun; 36(12):1947-54. PubMed ID: 3036156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-2 adrenergic activation of L-type Ca++ current in cardiac myocytes.
    Skeberdis VA; Jurevicius J; Fischmeister aR
    J Pharmacol Exp Ther; 1997 Nov; 283(2):452-61. PubMed ID: 9353357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms.
    Bristow MR; Minobe W; Rasmussen R; Larrabee P; Skerl L; Klein JW; Anderson FL; Murray J; Mestroni L; Karwande SV
    J Clin Invest; 1992 Mar; 89(3):803-15. PubMed ID: 1311717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors.
    Suzuki T; Nantel F; Bonin H; Valiquette M; Bouvier M
    J Pharmacol Exp Ther; 1993 Nov; 267(2):785-90. PubMed ID: 7902433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cardiac beta-adrenoceptors: both beta 1- and beta 2-adrenoceptors are functionally coupled to the adenylate cyclase in right atrium.
    Brodde OE; O'Hara N; Zerkowski HR; Rohm N
    J Cardiovasc Pharmacol; 1984; 6(6):1184-91. PubMed ID: 6084778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On minimum cyclic AMP formation rates associated with positive inotropic effects mediated through beta 1-adrenoceptors in kitten myocardium. Beta 1-specific and non-adrenergic stimulant effects of denopamine.
    Lemoine H; Teng KJ; Slee SJ; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):113-28. PubMed ID: 2566921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cyclic adenosine monophosphate release by selective β2-adrenergic receptor stimulation in human terminal failing myocardium before and after ventricular assist device support.
    Kassner A; Toischer K; Bohms B; Kolkhof P; Abraham G; Hasenfuβ G; Morshuis M; Schulte Eistrup S; El-Banayosy A; Gummert J; Milting H
    J Heart Lung Transplant; 2012 Oct; 31(10):1127-35. PubMed ID: 22975104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isoproterenol, denopamine, and atenolol-induced alterations in beta-adrenergic receptor-adenylate cyclase system of rat myocardium].
    Igarashi Y
    Hokkaido Igaku Zasshi; 1991 Sep; 66(5):647-57. PubMed ID: 1683639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta 2-adrenoceptor activation by zinterol causes protein phosphorylation, contractile effects and relaxant effects through a cAMP pathway in human atrium.
    Kaumann AJ; Sanders L; Lynham JA; Bartel S; Kuschel M; Karczewski P; Krause EG
    Mol Cell Biochem; 1996; 163-164():113-23. PubMed ID: 8974046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization of beta-adrenergic receptor-coupled adenylate cyclase activity. Differences following exposure of cells to two full agonists.
    Pittman RN; Rabin RA; Molinoff PB
    Biochem Pharmacol; 1984 Nov; 33(22):3579-84. PubMed ID: 6150707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy.
    Bristow MR; Anderson FL; Port JD; Skerl L; Hershberger RE; Larrabee P; O'Connell JB; Renlund DG; Volkman K; Murray J
    Circulation; 1991 Sep; 84(3):1024-39. PubMed ID: 1653120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity.
    Böhm M; Mittmann C; Schwinger RH; Erdmann E
    Am Heart J; 1990 Dec; 120(6 Pt 1):1381-92. PubMed ID: 1978979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A1-adenosine receptor inhibition of adenylate cyclase in failing and nonfailing human ventricular myocardium.
    Hershberger RE; Feldman AM; Bristow MR
    Circulation; 1991 Apr; 83(4):1343-51. PubMed ID: 1901530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of failing canine and human heart cells to beta 2-adrenergic stimulation.
    Altschuld RA; Starling RC; Hamlin RL; Billman GE; Hensley J; Castillo L; Fertel RH; Hohl CM; Robitaille PM; Jones LR
    Circulation; 1995 Sep; 92(6):1612-8. PubMed ID: 7664448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Details of mode and mechanism of action of denopamine, a new orally active cardiotonic agent with affinity for beta 1-receptors.
    Yokoyama H; Yanagisawa T; Taira N
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):323-31. PubMed ID: 2464105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of chick and frog beta adrenergic receptors in primary cultures of myocardial cells.
    Port JD; Debellis CC; Klein J; Peeters GA; Barry WH; Bristow MR
    J Pharmacol Exp Ther; 1992 Jul; 262(1):217-24. PubMed ID: 1352549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The resolution of dopamine and beta 1- and beta 2-adrenergic-sensitive adenylate cyclase activities in homogenates of cat cerebellum, hippocampus and cerebral cortex.
    Dolphin A; Hamont M; Bockaert J
    Brain Res; 1979 Dec; 179(2):305-17. PubMed ID: 41616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of a beta 3-receptor agonist (BRL 37,344) and a partial agonist (CGP 12,177A) in neonatal rat liver plasma membranes.
    Fraeyman N; Van Ermen A; Van de Velde E; Vanscheeuwijck P
    Biochem Pharmacol; 1992 Dec; 44(12):2333-8. PubMed ID: 1361733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.